Cravath, Swaine & Moore LLP Logo
  • Practices
  • People
  • Careers
  • News & Insights
  • Practices
  • People
  • Careers
  • News & Insights
  • Our Story
  • The Cravath System
  • Diversity & Inclusion
  • Pro Bono
  • Alumni Journal
  • 200.Cravath

Cravath Publishes Winter 2026 Issue of Alumni Journal

Read More

News & Insights

Arrangement of Financing for Zimmer Holdings, Inc.’s Acquisition of Biomet, Inc.

April 25, 2014

On April 24, 2014, Zimmer Holdings, Inc. and Biomet, Inc. announced that their respective Boards of Directors have approved a definitive agreement under which Zimmer will acquire Biomet in a cash and stock transaction valued at approximately $13.35 billion, including the assumption of net debt. Cravath represented Credit Suisse in connection with the arrangement of committed financing for the acquisition. The transaction, which is subject to customary closing conditions and regulatory approvals, is expected to close in the first quarter of 2015.

The Cravath team included partners Michael S. Goldman and William J. Whelan III and associates R. Kirkie Maswoswe and Cameron S. Stanton. Thurston J. Hamlette also worked on this matter.

Related Practices & Industries

  • Corporate
  • Healthcare and Life Sciences

People

Photo
Name
Michael S. Goldman
Title
Corporate
Title
Retired Partner
Email
mgoldman@cravath.com
Phone
+1-212-474-1999
vCard
Download vCard

    Education

    • J.D., 1987, Fordham University School of Law
      cum laude
    • B.A., 1984, University of Pennsylvania
      cum laude
    Photo
    Name
    William J. Whelan III
    Title
    Corporate
    Title
    Retired Partner
    Email
    wwhelan@cravath.com
    Phone
    +1-212-474-1999
    vCard
    Download vCard

      Education

      • J.D., 1983, Fordham University School of Law
        cum laude
      • B.A., 1980, University of Virginia
        with Distinction

      Related News & Insights

      Deals & Cases

      March 31, 2026

      Biogen’s $5.6 Billion Acquisition of Apellis

      On March 31, 2026, Biogen Inc. and Apellis Pharmaceuticals, Inc. announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of Apellis for $41.00 per share in cash at closing, or approximately $5.6 billion. Apellis stockholders will also receive a nontransferable CVR for each Apellis share held, entitling the holder to receive two payments of $2 per share each, contingent on certain annual global net sales thresholds being met for SYFOVRE®. Cravath is representing Biogen in connection with the transaction.

      Deals & Cases

      March 09, 2026

      Talkspace’s Acquisition by UHS

      On March 9, 2026, Universal Health Services, Inc. (“UHS”) announced that it has entered into a definitive agreement to acquire Talkspace, Inc. (“Talkspace”) for $5.25 per share. The enterprise value for the transaction is approximately $835 million. Cravath is representing Talkspace in connection with the transaction.

      Deals & Cases

      February 18, 2026

      Tenax’s Merger with Air

      On February 17, 2026, Tenax Aerospace Acquisition, LLC (“Tenax”) and Air Industries Group (“Air”) jointly announced that they have entered into an Agreement and Plan of Merger to combine Tenax’s special mission aviation business with Air’s precision aerospace manufacturing business. At the time of the merger, Air will issue shares of its common stock to holders of Tenax membership units. After the closing, Tenax shareholders are expected to own approximately 95% of Air’s outstanding shares while existing Air shareholders are expected to own approximately 5%, and the combined company expects to remain listed on the NYSE American under the symbol AIRI. Cravath is representing Tenax in connection with the transaction.

      Deals & Cases

      February 17, 2026

      Kennedy Wilson’s Acquisition by Consortium Led by William McMorrow and Fairfax

      On February 17, 2026, Kennedy‑Wilson Holdings, Inc. (“Kennedy Wilson”) and Fairfax Financial Holdings Limited (“Fairfax”) jointly announced that Kennedy Wilson has entered into a definitive agreement to be acquired, in an all cash‑transaction, by an entity affiliated with a consortium led by William McMorrow, Chairman and Chief Executive Officer of Kennedy Wilson, and certain other senior executives of Kennedy Wilson (collectively, the “KW Management Group”), together with Fairfax (collectively, the “Consortium”).

      Cravath Bicentennial

      Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.

      Explore

      Cravath, Swaine & Moore LLP Logo
      • CONTACT US
      • OUR STORY
      • ALUMNI PORTAL
      • DISCLAIMERS & NOTICES

      Attorney Advertising. ©2026 Cravath, Swaine & Moore LLP.